tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

REGN Stock Latest News

Regeneron initiated with an Outperform at Evercore ISI
The FlyRegeneron initiated with an Outperform at Evercore ISI
1d ago
REGN
Regeneron, Sanofi announce FDA acceptance for priority review of Dupixent sBLA
PremiumThe Fly
Regeneron, Sanofi announce FDA acceptance for priority review of Dupixent sBLA
2d ago
SNY
REGN
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
PremiumPress Releases
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
2d ago
REGN
Regeneron reports positive results from DB-OTO study
PremiumThe Fly
Regeneron reports positive results from DB-OTO study
7d ago
REGN
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
PremiumPress Releases
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
7d ago
REGN
Regeneron says FDA requested additional analyses during Dupixent sBLA review
PremiumThe FlyRegeneron says FDA requested additional analyses during Dupixent sBLA review
13d ago
REGN
Regeneron 10-Q cites FDA calling for more Dupi data, says RBC Capital
PremiumThe Fly
Regeneron 10-Q cites FDA calling for more Dupi data, says RBC Capital
13d ago
REGN
Regeneron lowers FY24 CapEx view to $780M-$880M from $825M-$950M
PremiumThe Fly
Regeneron lowers FY24 CapEx view to $780M-$880M from $825M-$950M
13d ago
REGN
Regeneron announces new $3B share repurchase program
PremiumThe Fly
Regeneron announces new $3B share repurchase program
13d ago
REGN
Regeneron reports Q1 adjusted EPS $9.55, consensus $10.10
PremiumThe Fly
Regeneron reports Q1 adjusted EPS $9.55, consensus $10.10
13d ago
REGN
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
13d ago
K
W
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
13d ago
K
W
Regeneron sees FY24 adjusted EPS $1.42-$1.49, consensus $1.46
PremiumThe FlyRegeneron sees FY24 adjusted EPS $1.42-$1.49, consensus $1.46
14d ago
REGN
Regeneron announces presentations on EYLEA HD, EYLEA Injection at ARVO meeting
PremiumThe Fly
Regeneron announces presentations on EYLEA HD, EYLEA Injection at ARVO meeting
16d ago
REGN
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
PremiumPress Releases
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
16d ago
REGN
Regeneron price target raised to $1,175 from $1,125 at Oppenheimer
PremiumThe Fly
Regeneron price target raised to $1,175 from $1,125 at Oppenheimer
19d ago
REGN
Regeneron, Mammoth collaborate to purse next-generation gene editing
PremiumThe Fly
Regeneron, Mammoth collaborate to purse next-generation gene editing
20d ago
REGN
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
PremiumPress Releases
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
21d ago
REGN
Regeneron price target raised to $1,030 from $1,020 at TD Cowen
PremiumThe Fly
Regeneron price target raised to $1,030 from $1,020 at TD Cowen
21d ago
REGN
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
PremiumPress ReleasesRegeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
22d ago
REGN
Regeneron price target raised to $720 from $710 at BofA
PremiumThe Fly
Regeneron price target raised to $720 from $710 at BofA
1M ago
REGN
RBC sees buying opportunity following Regeneron’s ‘overdone DOJ downside’
PremiumThe Fly
RBC sees buying opportunity following Regeneron’s ‘overdone DOJ downside’
1M ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >